Does anyone have an opinion on PRM.
No comparable news for a while.
Price seems to be sliding once again.

Thanks bluemango.
just seem to be waiting on the never/never. am still waiting on Alzeimers news.there doesnt seem to be any further update on licensing etc.
will have to keep on waiting.looks like the very long haul.

Disagree that it will be a further long haul. Even Pearce doesn't have infinite patience and he will now be looking for a return on his substantial stake in the company just like the rest of us. The take-up of TMT technology is also likely to be rapid according to market projections. Blue Oar wouldn't have given a 150p target if they saw this as years away. This is their current risk adjusted SOTP valuation, dependent only on the company signing the TMT deal, with Alzheimer's etc to come later.

Yes it's been a very long wait, but that doesn't necessarily mean it will continue to be. Far too many observers of this stock fall into the trap of simply extrapolating from past performance, rather than looking at the situation as it is today and the likely outcomes.

I am told from my reliably informed city source that a major announcement is only a matter of days and not weeks away..legal side of tying up matters has caused delay so far but not for much longer!..LOL on the way..patience will be rewarded!

Despite no news yet, we must be getting alot closer to the big "A" which will bring cheer to all who have held this long....should hear within next month definitely i am reassured!..time to consider topping up at these levels...38/40p!

After your post 5 you should have a "red face"!!

Can't say there's anything unrealistic about what blueface is saying. It only agrees broadly with what the company have been saying themselves, after all.

BIG "A" ANNOUNCED AT 18.03...!!!

It will be interesting to see what value is placed on this deal - - - it had better be good, eh?

I hold from some while ago and frankly, any excitement has long since gone.

Well,the big announcement has came and went.
Lots of sells,but also a lot of buys.

Hopefully will end the week above the 50p mark.

What is the licence worth in revenue terms?

Landsbanki have said in their brief up to date note that the Thermo Fisher deal would "conservatively" add another 24p to their original target price of 62p earlier this year.
They add that the royalties to PRM would be equivalent of 20% of sales on which PRM would be making a gross margin of 80%- which net TMT-based income could be "double their conservative estimates",etc.
They also mention that the challenge which had been lodged to its European TMT patent suggets that the Thermo believes the patent is secure.
I am reliably informed that the company will be making some further announcements in coming weeks..LOL for the everlasting patient shareholders!

Thermo Fisher will be rolling out Proteome's TMT(R)Tags at the 56th ASMS Conference on Mass Spectrometry and Applied Topics in Denver, USA from June 1st to 5th next week ...this will prove to be very interesting to see what the feedback will be !!..hopefully very positive in which case PRM shares are a steal still at current level of 39/40p!!...BUY..LOL will be on the way soon!

Another red day.No news seems to be the norm these days.Am still patiently waiting.Has anybody any information on the Alzheimers licence,it seems to have been put on the wayside for the moment.

21% down to c. 26p= = = = wow, what a waster!

Despite there being "good news soon" - something that's been "in the post..." for the last six years to my memory we investors have seen nothing. The Management of this co couldnt sell vinegar at a fish and chip convention.
. . . . . . . . . . . . . . The facts speak for themselves. . . . . . . . . . . . .
Er, Whatever they have, no-one wants .....at the price PRM wants to do a deal - that is if anyone needs a deal; for Life has gone on (on this planet) for millions of years without PRM's markers....and I guess it will continue that way...
expect 20p soon, as they will be wanting more cash to keep this beast rolling.
EDIT 01Aug08
Company expectations appear to have improved (heard that before!) with an Ann expected soon. However, as is common in small AIM-stocks no-one knows (what/ when /How-much, etc.) - so maybe we won't see 20p - more like 40p as this bears market-hallmarks of having reached its bottom.

I predict a BIG ANNOUNCEMENT soon

Market Reaction in last two days seems to indicate something coming VERY SOON.

Something's going on for sure - two lots of Price Monitoring Extensions on Thurs and Fri of this week, and sp shot up. Just can't think what's going on as I've not followed this for a while, though did notice the rise in last couple of days. Think I may leap back on board first thing Monday.

... on second thoughts: sp is indicating down this morning. Will keep an eye on it

No obvious NEWs yet - so what caused the big rise ( almost doubled!).?
Maybe a perception that this technology has some merit and will be big one day. Maybe it's a better understanding of the Dir-Loan (being in Shareholder interest?) and so on.
Without solid news this could slip back as folk depart, taking a small profit as is tempting.....or do you hang-on in there to reaqp the potential rewards?

This Co has always told the Market there is a Big-Deal round the corner...and maybe one day there will be.
What's odd, is that with a technology so good - why aren't Drug-Co's snapping them up? . . . . . . that remains a worry, but IF there is a good deal - then this should multiply - I have a small holding from c. sub30p and somewhat more higher...I guess I might be near-evens currently, but if it goes well, I shall be happy enough.
Current Markets strip-out losers....just hope this survives OK.

I'm not feeding this one....waiting will do.

"What's odd, is that with a technology so good - why aren't Drug-Co's snapping them up?"

The director loan and its current terms involving the IP and potential conversion are in effect a 'poison pill' for any would-be predator. CJP's game-plan will probably involve an agreed takeover at some future time, but not before full value has been added. The two main cash inflows still to come are, firstly, sub-licences from current infringers of the TMT patents thus allowing TF and PRM to tap into current/future royalty streams, plus a large element for back-royalties due to PRM. Secondly they are still pursuing a 30m euros warranties claim with Sanofi-Aventis. Both could result in multi-million windfall payments to Proteome, and may be a motivation behind some of the recent buying.

This is all quite apart from possible commercial deals for HTS biomarkers and for Alzheimer's biomarkers.

Nothing new in the above of course, which is why the Company still have something of a credibility hill to climb. So until any of the above actually occur, there's still an element of gamble here, but with corporate activity involving ABI this Autumn, the odds are at last looking to shift in Proteome's favour.